ホーム > 藤巻基紀/ FUJIMAKI, Motoki

藤巻基紀

FUJIMAKI, Motoki

医学医療系 , 講師
Institute of Medicine , Assistant Professor

21. Mendelian neurodegenerative disease genes involved in autophagy. Eleanna Stamatakou; Lidia Wróbel; Sandra Malmgren Hill; Claudia Puri (+8 著者) David Chaim Rubinsztein
Cell discovery 6: 24 (2020) Semantic Scholar
22. Neuroprotective effects of memantine via enhancement of autophagy. Kazuoki Hirano; Motoki Fujimaki; Yukiko Sasazawa; Akihiro Yamaguchi (+9 著者) Nobutaka Hattori
Biochemical and biophysical research communications 518: 161 (2019) Semantic Scholar
23. A metabolic profile of polyamines in parkinson disease: A promising biomarker. Shinji Saiki; Yukiko Sasazawa; Motoki Fujimaki; Koji Kamagata (+15 著者) Nobutaka Hattori
Annals of neurology 86: 251 (2019) Semantic Scholar
24. Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions. Motoki Fujimaki; Norihiko Furuya; Shinji Saiki; Taku Amo (+1 著者) Nobutaka Hattori
Molecular and cellular biology 39: (2019) Semantic Scholar
25. Metabolomics-based identification of metabolic alterations in PARK2. Ayami Okuzumi; Taku Hatano; Shin-Ichi Ueno; Takashi Ogawa (+9 著者) Nobutaka Hattori
Annals of clinical and translational neurology 6: 525 (2019) Semantic Scholar
26. Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy. Akio Mori; Kei-Ichi Ishikawa; Shinji Saiki; Taku Hatano (+6 著者) Nobutaka Hattori
PloS one 14: e0223113 (2019) Semantic Scholar
27. Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's Disease. Shin-Ichi Ueno; Shinji Saiki; Motoki Fujimaki; Haruka Takeshige-Amano (+6 著者) Nobutaka Hattori
Cells 8: (2018) Semantic Scholar
28. Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease. Motoki Fujimaki; Shinji Saiki; Yuanzhe Li; Naoko Kaga (+12 著者) Nobutaka Hattori
Neurology 90: e404-e411 (2018) Semantic Scholar
29. Immunocytochemical Monitoring of PINK1/Parkin-Mediated Mitophagy in Cultured Cells. Motoki Fujimaki; Shinji Saiki; Yukiko Sasazawa; Kei-Ichi Ishikawa (+2 著者) Nobutaka Hattori
Methods in molecular biology (Clifton, N.J.) 1759: 19 (2018) Semantic Scholar
30. Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease. Shinji Saiki; Taku Hatano; Motoki Fujimaki; Kei-Ichi Ishikawa (+11 著者) Nobutaka Hattori
Scientific reports 7: 7328 (2017) Semantic Scholar
31. Parkinsonism in a patient with valosin-containing protein gene mutation showing: a case report. Motoki Fujimaki; Kazuaki Kanai; Sayaka Funabe; Masashi Takanashi (+2 著者) Nobutaka Hattori
Journal of neurology 264: 1284 (2017) Semantic Scholar
32. Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma. Kenya Nishioka; Motoki Fujimaki; Kazuaki Kanai; Yuta Ishiguro (+3 著者) Nobutaka Hattori
Internal medicine (Tokyo, Japan) 56: 101 (2017) Semantic Scholar
33. Cerebrospinal fluid dissemination of anaplastic intraventricular meningioma: report of a case presenting with progressive brainstem dysfunction and multiple cranial nerve palsies. Motoki Fujimaki; Masashi Takanashi; Manami Kobayashi; Kei-ichiro Wada (+3 著者) Hideto Miwa
BMC neurology 16: 82 (2016) Semantic Scholar
34. Acute psychosis as an initial manifestation of hypothyroidism: a case report. Shinichi Ueno; Satoko Tsuboi; Motoki Fujimaki; Hiroto Eguchi (+2 著者) Hideto Miwa
Journal of medical case reports 9: 264 (2015) Semantic Scholar
35. Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study. Motoki Fujimaki; Sumihiro Kawajiri; Kunimoto Ichikawa; Yuji Tomizawa (+4 著者) Yasuyuki Okuma
CNS neuroscience & therapeutics 21: 610 (2015) Semantic Scholar
36. Eosinophilic meningitis caused by primary angiitis of the central nervous system. Kazuoki Hirano; Jiro Fukae; Sotaro Hieda; Motoki Fujimaki (+4 著者) Nobutaka Hattori
Internal medicine (Tokyo, Japan) 52: 1393 (2013)

« 1 2

1. 脳神経内科第100巻第4号藤巻, 基紀
科学評論社 2024年4月
2. 日本臨床 2023年8月号特集パーキンソン病2023 ―基礎・臨床の最新動向― 藤巻, 基紀
株式会社日本臨床社 2023年8月
3. パーキンソン病におけるカフェイン代謝変化と診断への意義藤巻, 基紀
CMC出版 2018年9月

1. 神経疾患におけるFcRn阻害薬：全身型重症筋無力症（gMG）および慢性炎症性脱髄性多発神経炎（CIDP）に対するエフガルチギモドの臨床応用と役割
第54回日本免疫学会学術集会 2025年12月11日招待有り
2. Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis FUJIMAKI, Motoki
第65回日本神経学会学術大会 / AOCN2024 日本神経学会

知財情報はまだありません。

465 total views

この研究者の他の情報源

キーワードが似ている研究者

林洋平 ALUMNI induced pluripotent stem cells, iPS細胞
今川和生 iPS細胞
片浦哲志 iPS細胞
福田綾 iPS細胞
久野朗広 iPS細胞

この研究者の他の情報源

キーワードが似ている研究者

この研究者の情報を共有